陳怡燕 / Yi-Yen Chen
Professional Experience
- Associate Director, PCI Ventures, University of Pennsylvania, Philadelphia, USA, 2023/2-Present
- Managing Director, Venture Capital, Echo Investment Capital, Oklahoma City, USA, 2021/5-2023/2
- Principal (2020/1-2021/5), Senior Associate (2018/7-2019/12), Venture Capital Fellow (2017/7-2018/6), WI Harper Group, San Francisco, USA, 2017/7-2021/5
- Assistant Manager in International Business Development, Microbio Group, Taipei, Taiwan, 2016/6-2017/4
- Postdoctoral Fellow, The Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands, 2014/9-2016/6
- Postdoctoral Fellow, Institute of Molecular Biology (IMB) gGmbH, Mainz, Germany, 2013/3-2014/9
- Assistant Manager/Project Leader Zebrafish Antibody Portfolio, GeneTex Inc., Hsinchu, Taiwan, 2012/1-2012/12
- Research Assistant, Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan, 2001/7-2003/6
Board Memberships
- Board Member, Mechano Therapeutics, Philadelphia, Pennsylvania, USA, 2023/2-Present
- Board Member, EpiVario, Philadelphia, Pennsylvania, USA, 2023/2-Present
- Board Member, DEKA BioSciences, Germantown, Maryland, USA, 2021/11-2023/2
- Board Observer, IVIVA Medical, Beverly, MA, USA, 2020/12-2021/5
Education
- Ph.D., Biology, Max-Planck Institute for Developmental Biology/Eberhard Karls University, Tübingen, Germany, 2005/8-2011/12
- Master of Science, National Taiwan University, Taipei, Taiwan, 1999/9-2001/6
- Bachelor of Science, Public Health, Kaohsiung Medical University, Kaohsiung, Taiwan, 1994/9-1998/6